| Dr Vaibhav Vinubhai Patel, MD | |
|
2300 Manchester Expy Ste 1001, Butler Pavilion, Columbus, GA 31904-6802 | |
| (706) 322-0528 | |
| (706) 322-2080 |
| Full Name | Dr Vaibhav Vinubhai Patel |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 33 Years |
| Location | 2300 Manchester Expy Ste 1001, Columbus, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386670073 | NPI | - | NPPES |
| 887727511B | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 060025 (Georgia) | Secondary |
| 174400000X | Specialist | 060025 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Hospital- Emory Healthcare | Columbus, GA | Hospital |
| Piedmont Columbus Regional Midtown | Columbus, GA | Hospital |
| Piedmont Columbus Regional Northside | Columbus, GA | Hospital |
| Jack Hughston Memorial Hospital | Phenix city, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Francis Physician Practices Llc | 8729381033 | 81 |
| Chhokar Clinic | 6800883463 | 5 |
News Archive
The ever growing complexity of various simulation tasks not only require a continuous increase of computing power but also the capability of managing large amounts of data.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Jing Yang, an assistant professor in the College of Engineering at the University of Arkansas, has received a $500,000 Faculty Early Career Development Program award from the National Science Foundation to continue developing sensing and transmission systems for energy-harvesting, wireless sensor networks.
A reformulation of OxyContin that makes it harder to abuse has curtailed the drug's illicit use. But some 25 percent of drug abusers entering rehab said they still abused the prescription painkiller despite package labeling that emphasizes its abuse-deterrent properties, new research indicates.
While colonoscopies are the most accurate method for the early detection of colorectal cancers, screening with fecal occult blood tests results in more efficient use of limited budgets, according to a new study by researchers at RTI International.
› Verified 3 days ago
| Entity Name | Columbus Ambulatory Healthcare Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790733244 PECOS PAC ID: 1355244385 Enrollment ID: O20040128000790 |
News Archive
The ever growing complexity of various simulation tasks not only require a continuous increase of computing power but also the capability of managing large amounts of data.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Jing Yang, an assistant professor in the College of Engineering at the University of Arkansas, has received a $500,000 Faculty Early Career Development Program award from the National Science Foundation to continue developing sensing and transmission systems for energy-harvesting, wireless sensor networks.
A reformulation of OxyContin that makes it harder to abuse has curtailed the drug's illicit use. But some 25 percent of drug abusers entering rehab said they still abused the prescription painkiller despite package labeling that emphasizes its abuse-deterrent properties, new research indicates.
While colonoscopies are the most accurate method for the early detection of colorectal cancers, screening with fecal occult blood tests results in more efficient use of limited budgets, according to a new study by researchers at RTI International.
› Verified 3 days ago
| Entity Name | Chhokar Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619079100 PECOS PAC ID: 6800883463 Enrollment ID: O20040427000953 |
News Archive
The ever growing complexity of various simulation tasks not only require a continuous increase of computing power but also the capability of managing large amounts of data.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Jing Yang, an assistant professor in the College of Engineering at the University of Arkansas, has received a $500,000 Faculty Early Career Development Program award from the National Science Foundation to continue developing sensing and transmission systems for energy-harvesting, wireless sensor networks.
A reformulation of OxyContin that makes it harder to abuse has curtailed the drug's illicit use. But some 25 percent of drug abusers entering rehab said they still abused the prescription painkiller despite package labeling that emphasizes its abuse-deterrent properties, new research indicates.
While colonoscopies are the most accurate method for the early detection of colorectal cancers, screening with fecal occult blood tests results in more efficient use of limited budgets, according to a new study by researchers at RTI International.
› Verified 3 days ago
| Entity Name | St Francis Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326749417 PECOS PAC ID: 8729381033 Enrollment ID: O20160120002073 |
News Archive
The ever growing complexity of various simulation tasks not only require a continuous increase of computing power but also the capability of managing large amounts of data.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Jing Yang, an assistant professor in the College of Engineering at the University of Arkansas, has received a $500,000 Faculty Early Career Development Program award from the National Science Foundation to continue developing sensing and transmission systems for energy-harvesting, wireless sensor networks.
A reformulation of OxyContin that makes it harder to abuse has curtailed the drug's illicit use. But some 25 percent of drug abusers entering rehab said they still abused the prescription painkiller despite package labeling that emphasizes its abuse-deterrent properties, new research indicates.
While colonoscopies are the most accurate method for the early detection of colorectal cancers, screening with fecal occult blood tests results in more efficient use of limited budgets, according to a new study by researchers at RTI International.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vaibhav Vinubhai Patel, MD 2300 Manchester Expy Ste 1001, Butler Pavilion, Columbus, GA 31904-6802 Ph: (706) 322-0528 | Dr Vaibhav Vinubhai Patel, MD 2300 Manchester Expy Ste 1001, Butler Pavilion, Columbus, GA 31904-6802 Ph: (706) 322-0528 |
News Archive
The ever growing complexity of various simulation tasks not only require a continuous increase of computing power but also the capability of managing large amounts of data.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Jing Yang, an assistant professor in the College of Engineering at the University of Arkansas, has received a $500,000 Faculty Early Career Development Program award from the National Science Foundation to continue developing sensing and transmission systems for energy-harvesting, wireless sensor networks.
A reformulation of OxyContin that makes it harder to abuse has curtailed the drug's illicit use. But some 25 percent of drug abusers entering rehab said they still abused the prescription painkiller despite package labeling that emphasizes its abuse-deterrent properties, new research indicates.
While colonoscopies are the most accurate method for the early detection of colorectal cancers, screening with fecal occult blood tests results in more efficient use of limited budgets, according to a new study by researchers at RTI International.
› Verified 3 days ago